NAD+ kinase

NAD+ kinase (NADK) is an enzyme that plays a crucial role in cellular metabolism by catalyzing the phosphorylation of nicotinamide adenine dinucleotide (NAD+) to produce nicotinamide adenine dinucleotide phosphate (NADP+). This reaction is significant because NADP+ serves as a critical cofactor in anabolic reactions, including lipid and nucleic acid synthesis, by providing the necessary reducing power.
Function[edit]
NAD+ kinase is primarily involved in the regulation of oxidative stress and cellular redox state. By converting NAD+ to NADP+, it helps maintain the balance between the oxidized and reduced forms of nicotinamide adenine dinucleotide phosphate, namely NADP+ and NADPH. NADPH is essential for the antioxidant defense of cells, as it is a cofactor for glutathione reductase and other enzymes involved in the reduction of reactive oxygen species (ROS).
Structure[edit]
The structure of NAD+ kinase varies among different organisms, but it generally contains a conserved NAD+ binding domain. In some species, NADK is localized in the cytoplasm, while in others, it is found in mitochondria or chloroplasts, indicating a compartment-specific role in cellular metabolism.
Regulation[edit]
The activity of NAD+ kinase is regulated by various factors, including the availability of its substrate NAD+ and the energy status of the cell. In some cases, calcium ions (Ca2+) have been shown to activate NADK, linking it to calcium signaling pathways and further underscoring its role in the response to cellular stress.
Clinical Significance[edit]
Alterations in NAD+ kinase activity have been implicated in several diseases, including diabetes, cancer, and neurodegenerative disorders. For example, overexpression of NADK has been observed in certain types of cancer, suggesting a potential role in cancer metabolism. Conversely, reduced NADK activity can lead to impaired NADPH production and increased susceptibility to oxidative damage, contributing to the pathogenesis of metabolic and neurodegenerative diseases.
Research[edit]
Research on NAD+ kinase has focused on elucidating its regulatory mechanisms, structure-function relationships, and potential as a therapeutic target. Inhibitors of NADK are being explored for their potential to modulate NADP+/NADPH levels and influence cellular redox states, offering new avenues for the treatment of diseases associated with oxidative stress and metabolic dysregulation.

This article is a biochemistry stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian